Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 6.11
Day High 6.44
Open:6.13
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Aphria Inc and its subsidiaries produce and sell medical marijuana. Its products include Capsules, Oral solutions, and Vaporizers. The company's operations are based in Leamington, Ontario. It is focused on producing and selling medical marijuana and its derivatives through retail sales and wholesale channels. It operates through following segments: Cannabis operations which encompasses the production, distribution and sale of both medical and adult-use cannabis, Distribution operations and Businesses under development segment.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

The Psilocybin Mushroom Story Could be the Next Big Investment Boom
- PR Newswire - Thu Oct 10, 7:50AM CDT
PR Newswire - CMTX
Thu Oct 10, 7:50AM CDT
As the cannabis market booms, another drug may soon follow in its footsteps -- psilocybin mushrooms. Already, we're seeing a groundswell of interest. In fact, activists in California are working on getting its decriminalization added to the 2020 ballot. The proposed amendment - called the California Psilocybin Decriminalization Initiative -- would revise state drug laws to decriminalize the "personal possession, storage, use, cultivation, manufacturing, distribution in personal possession amounts, according to Marijuana Moment. Better, the U.S. FDA already granted 'breakthrough status' to COMPASS Pathways' psilocybin-assisted therapy in October 2018, which allows the FDA assist in the development of a promising drug to treat serious illnesses. In addition, researchers at New York University found psilocybin mushrooms caused a 'rapid and sustained' reduction in anxiety and depression in patients with cancer," as reported by the Financial Post. As excitement builds, it's opening a range of opportunity for companies that have already established launching cannabis products including The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), GW Pharmaceuticals (NASDAQ:GWPH), Tilray Inc. (NASDAQ:TLRY), Aphria Inc. (NYSE:APHA) (TSX:APHA), and The Green Organic Dutchman (TSX:TGOD)(OTCQX:TGODF).
Aphria Inc. Statement Regarding Emblem Corp. Wholesale Cannabis Supply Agreement
- PR Newswire - Tue Oct 8, 7:53AM CDT
PR Newswire - CMTX
Tue Oct 8, 7:53AM CDT
Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today issued the following statement in regards to Aleafia Health Inc.'s ("Aleafia") termination of the Company's wholesale cannabis supply agreement ("Agreement") with Emblem Corp.("Emblem"):
Aphria Inc. Statement Regarding Emblem Corp. Wholesale Cannabis Supply Agreement
- PR Newswire - Tue Oct 8, 7:53AM CDT
PR Newswire - PRNW
Tue Oct 8, 7:53AM CDT
LEAMINGTON, ON , Oct. 8, 2019 /PRNewswire/ - Aphria Inc. (" Aphria " or the " Company ") ( TSX: APHA  and NYSE: APHA ) today issued the following statement in regards to Aleafia Health Inc.'s (" Aleafia ") termination of the Company's wholesale cannabis supply agreement (" Agreement ") with Emblem Corp.(" Emblem "):
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 5.90 +5.25% increase
on 10/10/19
Period Open:9.09
Price movement based on the high, low and last over the given period.
9.06 -31.46% decrease
on 09/12/19
-2.88 (-31.68%) decrease
since 09/11/19
3-Month 5.90 +5.25% increase
on 10/10/19
Period Open:8.53
Price movement based on the high, low and last over the given period.
10.05 -38.21% decrease
on 08/06/19
-2.32 (-27.20%) decrease
since 07/11/19
52-Week 4.76 +30.46% increase
on 12/05/18
Period Open:19.70
Price movement based on the high, low and last over the given period.
20.96 -70.37% decrease
on 10/16/18
-13.49 (-68.48%) decrease
since 10/11/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).